Protective immunity to infection from encapsulated bacteria is mediated predominantly by antibody (Ab) to their capsular polysaccharide (CP). The human Ab repertoire to the CP of such encapsulated bacteria is often highly restricted in diversity with use of a limited number of immunoglobulin heavy chain variable region (V/H) and light chain variable region (V/L) genes. The ontogeny of the human Ab response to the Haemophilus influenzae type b (Hib) Hib and multiple pneumococcal CP are delayed in the infant, which is the age of highest risk of infection with encapsulated bacteria. The mechanism of this delay in ontogeny is unknown. We hypothesize that contributing to this delay are poor expression of particular V genes and of N region addition, a process of nontemplated nucleotide addition mediated by the enzyme terminal deoxynucleotidyl transferase. N region addition is delayed in ontogeny in the mouse and particularly in murine CD5 positive B cells, which have been implicated in murine Ab production to CP.
The aims of this proposal are to: 1) determine whether the neonate's kappa light chain variable region (Vkappa) repertoire is skewed compared to the adult's; 2) determine the ontogeny of N region addition at the Vkappa-Jkappa junction; 3) develop approaches to defining human Ab repertoires to CP. The results should provide insights into ontogeny of human Ab responses and a background for developing vaccines to prevent bacterial infections in infants.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Research Project (R01)
Project #
1R01AI037123-01
Application #
2073742
Study Section
Special Emphasis Panel (SRC (84))
Project Start
1994-09-30
Project End
1997-08-31
Budget Start
1994-09-30
Budget End
1995-08-31
Support Year
1
Fiscal Year
1994
Total Cost
Indirect Cost
Name
University of Rochester
Department
Pediatrics
Type
Schools of Dentistry
DUNS #
208469486
City
Rochester
State
NY
Country
United States
Zip Code
14627
Wenger, Yvan; Schneider 2nd, Randal J; Reddy, G Ramachandra et al. (2011) Tissue distribution and pharmacokinetics of stable polyacrylamide nanoparticles following intravenous injection in the rat. Toxicol Appl Pharmacol 251:181-90
Kim, Gwangseong; Lee, Yong-Eun Koo; Xu, Hao et al. (2010) Nanoencapsulation method for high selectivity sensing of hydrogen peroxide inside live cells. Anal Chem 82:2165-9
Lee, Sang C; Bottaro, Andrea; Chen, Luojing et al. (2006) Mad1 is a transcriptional repressor of Bcl-6. Mol Immunol 43:1965-71
Lee, Sang C; Bottaro, Andrea; Insel, Richard A (2003) Activation of terminal B cell differentiation by inhibition of histone deacetylation. Mol Immunol 39:923-32
Kuzin, I I; Snyder, J E; Ugine, G D et al. (2001) Tetracyclines inhibit activated B cell function. Int Immunol 13:921-31
Varade, W S; Carnahan, J A; Kingsley, P D et al. (1998) Inherent properties of somatic hypermutation as revealed by human non-productive VH6 immunoglobulin rearrangements. Immunology 93:171-6
Insel, R A; Varade, W S (1998) Characteristics of somatic hypermutation of human immunoglobulin genes. Curr Top Microbiol Immunol 229:33-44
Hu, B T; Lee, S C; Marin, E et al. (1997) Telomerase is up-regulated in human germinal center B cells in vivo and can be re-expressed in memory B cells activated in vitro. J Immunol 159:1068-71
Chu, Y W; Marin, E; Fuleihan, R et al. (1995) Somatic mutation of human immunoglobulin V genes in the X-linked HyperIgM syndrome. J Clin Invest 95:1389-93